Related Experiment Video
Updated: Nov 8, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MicroRNA-1226-3p has a tumor-promoting role in osteosarcoma
1Department of Orthopedics, Sixth Medical Center of the PLA General Hospital, Beijing 100048, P.R. China.
Abstract:
Osteosarcoma is a malignant bone tumor that commonly occurs in young individuals. It accounts for 10% of solid tumors in those who are 15-19 years old. MicroRNA (miRNA/miR) dysregulation serves a crucial role in the molecular mechanism of osteosarcoma. The present study reported a novel miRNA (miR-1226-3p) and investigated its function in osteosarcoma. miR-1226-3p mimics and miR-1226-3p antisense oligonucleotides were transfected into human osteosarcoma SaOS-2 cells to alter miR-1226-3 expression, while the hFOB 1.19 cell line was used as the control. The apoptosis rate was analyzed using a dead cell apoptosis kit. TNF receptor-associated factor 3 (TRAF3) protein expression was assayed by western blotting. The results of bioinformatics and clinical specimen analyses revealed that higher expression levels of miR-1226-3p were associated with lower survival rates. Additionally, the results of experiments on cultured cells revealed that miR-1226-3p promoted the proliferation of SaOS-2 cells, while miR-1226-3p inhibition decreased cell proliferation and increased apoptosis. Furthermore, it was revealed that miR-1226-3p targeted TRAF3 in SaOS-2 cells. In conclusion, the present study suggested that miR-1226-3p promoted the proliferation of osteosarcoma cells.
Insights
MicroRNA (miRNA) miR-1226-3p promotes osteosarcoma cell growth. Inhibiting miR-1226-3p in bone cancer cells reduced proliferation and increased cell death, suggesting a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is a common bone cancer in adolescents and young adults, accounting for 10% of solid tumors in this age group.
- MicroRNA (miRNA) dysregulation is implicated in the molecular pathogenesis of osteosarcoma.
Purpose of the Study:
- To investigate the role of a novel miRNA, miR-1226-3p, in osteosarcoma.
- To determine the functional impact of miR-1226-3p on osteosarcoma cell proliferation and apoptosis.
- To identify the molecular targets of miR-1226-3p in osteosarcoma.
Main Methods:
- Transfection of human osteosarcoma SaOS-2 cells with miR-1226-3p mimics and antisense oligonucleotides.
- Assessment of cell apoptosis using a dead cell apoptosis kit.
- Analysis of TNF receptor-associated factor 3 (TRAF3) protein expression via western blotting.
- Bioinformatics and clinical specimen analyses.
Main Results:
- Higher miR-1226-3p expression levels correlated with reduced survival rates in osteosarcoma patients.
- miR-1226-3p overexpression promoted proliferation in SaOS-2 cells.
- Inhibition of miR-1226-3p decreased cell proliferation and increased apoptosis in SaOS-2 cells.
- miR-1226-3p was found to target TRAF3 in osteosarcoma cells.
Conclusions:
- miR-1226-3p plays a significant role in promoting osteosarcoma cell proliferation.
- miR-1226-3p may serve as a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

